Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-01
2010-12-28
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07858638
ABSTRACT:
Methods of treating stuttering include treating people with gamma-aminobutyric acid (GABA) receptor modulators, including cyclopyrrolones. A second active agent may be used with GABA receptor modulators. Active enantiomers, active metabolites, and pharmaceutically acceptable salts of gamma-aminobutyric acid receptor modulators, including cyclopyrrolones, are acceptable components of the compositions. The cyclopyrrolone class of modulators includes pagoclone, suriclone, zopiclone, 2-(7-chloro-2-naphthyridin-1,8-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one, 2-(7-chloro-2-naphthyridin-1,8-yl)isoindolin-1-yl-4-acetamidobutyrate, and 2-(7-chloro-1,8-naphthyridin-2yl)-3-(5-methyl-5-hydroxy-2-oxohexyl)-1-isoindolinone.
REFERENCES:
patent: 4401663 (1983-08-01), Buckwalter et al.
patent: 4788055 (1988-11-01), Fischer et al.
patent: 4816264 (1989-03-01), Phillips et al.
patent: 4828836 (1989-05-01), Elger et al.
patent: 4834965 (1989-05-01), Martani et al.
patent: 4834985 (1989-05-01), Elger et al.
patent: 4960779 (1990-10-01), Bourzat et al.
patent: 4996047 (1991-02-01), Kelleher et al.
patent: 5071646 (1991-12-01), Malkowska et al.
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5494915 (1996-02-01), Barreau et al.
patent: 5599936 (1997-02-01), Barreau et al.
patent: 5676831 (1997-10-01), Barreau et al.
patent: 9800727 (1998-05-01), None
Supprain et al., American Journal of Psychiatry, 1991, 156:10, 1663-1664.
Brady, J Clin Psychopharmacology, 1998;18(1):50-54.
Brady et al. 1991 “The Pharmacology of Stuttering: A Critical Review” Am J Psychiatry 148:1309-1316.
Wells et al. 1971 “Control Trial of the Treatment of 36 Stutterers” Brit. J. Psychiat. 119: 603-4.
Rentschler et al. 1984 “The Onset of Stuttering Following Drug Overdose” J. Fluency Disord. 9: 265-284.
Brewerton et al. 1996 “Stuttering With Sertaline” J Clin Psychiatry 57(2):90-1.
Vink et al. 1992 “Clonidine and stuttering” Am J. Psychiatry 149(5):717-8.
Costa 1992 “Antidepressants and the treatment of stuttering” Am J Psychiatry 149(9):1281.
Christensen et al. 1996 “A Case of Sertraline-Induced Stuttering” J Clin Psychopharmacol 16(1): 92-93.
Makela et al. 1996 “Reply [to Christensen et al.]” J Clin Psychopharmacol 16(1):93.
Brady 1992 “Dr. Brady Replies [to Vink et al.]” Am J. Psychiatry 149(56):718.
Brady 1992 “Dr. Brady Replies [to Costa]” Am J. Psychiatry 149(9):1281.
Stager et al. 1995 “Fluency Changes in Persons Who Stutter Following a Double Blind Trial of Clomipramine and Desipramine” J Speech Hear Res. 38:516-25.
Schreiber et al 1997 “Paroxetine for secondary stuttering: further interaction of serotonin and dopamine”J Nerv Ment Dis. 185(7):465-7.
Fernandez et al. 1995 “Clinical Pharmacokinetics of Zopiclone”; Clin Pharmacokinet, 29(6): 431-41.
Doble et al. 1993 “RP 59037 and RP 60503: Anxiolytic Cyclopyrrolone Derivatives with Low Sedative Potential. Interaction with the γ-Aminobutyric Acidimg id="CUSTOM-CHARACTER-00001" he="3.13mm" wi="1.78mm" file="US07858638-20101228-P00001.TIF" alt="custom character" img-content="character" img-format="tif" ?/Benzodiazepine Receptor Complex and Behavioral Effects in the Rodent” J Pharmacol Exp Ther. 266(3):1213-26.
Korpi et al. 1997 “GABAimg id="CUSTOM-CHARACTER-00002" he="3.13mm" wi="1.78mm" file="US07858638-20101228-P00001.TIF" alt="custom character" img-content="character" img-format="tif" ?-receptor Subtypes: Clinical Efficacy and Selectivity of Benzodiazepine Site Ligands” Annals Med 29:275-282; Erratum 1997 Annals Med 29: 275-82.
Kiziltan et al. 1996 “Stuttering May Be a Type of Action Dystonia” Movement Disorders 11(3): 278-282.
Swinyard 1990 “Sedatives and Hypnotics”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1057-1071.
Di Santo 1990 “Bioavailability and Bioequivalency Testing”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1451-1458.
Vadas1990 “Stability of Pharmaceutical Products”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co.,Easton, PA, pp. 1504-1512.
Naim 1990 “Solutions, Emulsions, Suspensions and Extracts”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1519-1544.
Avis 1990 “Parenteral Preparations”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1545-1569.
O'Connor et al. 1990 “Powders”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1615-1632.
Rudnic et al. 1990 “Oral Solid Dosage Forms”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1633-1665.
Porter 1990 “Coating of Pharmaceutical Dosage Forms”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1666-1675.
Longer et al. 1990 “Sustained-Release Drug Delivery Systems”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1676-1693.
Brady 1998 “Drug-Induced Stuttering: A Review of the Literature”, J. Clin. Psychopharmacol. 18(1):50-4.
Elliott et al. 1985 “A Case Report of Alprazolam Induced Stuttering”, J. Clin. Psychopharmacol 5(3):159-60.
D'Orlando Kay Jorgenson
Murphy John J.
Endo Pharmaceuticals Solutions Inc.
Foley & Lardner LLP
Hui San-ming
Reid Steven M.
Villacorta Gilberto M.
LandOfFree
Methods and compositions for alleviating stuttering does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for alleviating stuttering, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for alleviating stuttering will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4150852